Evidence map›Paper›PMID 30994358›Full record

ArticleMolecular pharmaceutics2019

An Integrated Microfluidic Platform for Quantifying Drug Permeation across Biomimetic Vesicle Membranes.

Michael Schaich, Jehangir Cama, Kareem Al Nahas, Diana Sobota, Hannah Sleath, Kevin Jahnke, Siddharth Deshpande, Cees Dekker, Ulrich F Keyser

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmaceutics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 46 citations in OpenAlex.

  1. The Ion Permeability of DNA Nanotube Channels.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. High Macromolecular Crowding in Liposomes from Microfluidics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Michael SchaichCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.ORCID 0000-0001-5432-9598
Jehangir CamaCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.ORCID 0000-0002-5982-1941
Kareem Al NahasCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.
Diana SobotaCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.
Hannah SleathCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.
Kevin JahnkeCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.ORCID 0000-0001-7311-6993
Siddharth DeshpandeDepartment of Bionanoscience, Kavli Institute of Nanoscience , Delft University of Technology , Van der Maasweg 9 , 2629 HZ Delft , The Netherlands.ORCID 0000-0002-7137-8962
Cees DekkerDepartment of Bionanoscience, Kavli Institute of Nanoscience , Delft University of Technology , Van der Maasweg 9 , 2629 HZ Delft , The Netherlands.ORCID 0000-0001-6273-071X
Ulrich F KeyserCavendish Laboratory , University of Cambridge , JJ Thomson Avenue , Cambridge CB3 0HE , U.K.
University of Cambridge · GBDelft University of Technology · NLHeidelberg University · DEUniversity of Exeter · GB

Funding

European Research Council 669598Wellcome Trust 204909
6 · The paper itself

Abstract

The low membrane permeability of candidate drug molecules is a major challenge in drug development, and insufficient permeability is one reason for the failure of antibiotic treatment against bacteria. Quantifying drug transport across specific pathways in living systems is challenging because one typically lacks knowledge of the exact lipidome and proteome of the individual cells under investigation. Here, we quantify drug permeability across biomimetic liposome membranes, with comprehensive control over membrane composition. We integrate the microfluidic octanol-assisted liposome assembly platform with an optofluidic transport assay to create a complete microfluidic total analysis system for quantifying drug permeability. Our system enables us to form liposomes with charged lipids mimicking the negative charge of bacterial membranes at physiological pH and salt concentrations, which proved difficult with previous liposome formation techniques. Furthermore, the microfluidic technique yields an order of magnitude more liposomes per experiment than previous assays. We demonstrate the feasibility of the assay by determining the permeability coefficient of norfloxacin and ciprofloxacin across biomimetic liposomes.

Indexed as

Anti-Bacterial AgentsBiomimeticsCiprofloxacinDrug Delivery SystemsLab-On-A-Chip DevicesLiposomesMicrofluidicsNorfloxacinAnti-Bacterial AgentsCiprofloxacinLiposomesNorfloxacinantibioticsdrug transportGUVlab on chipliposomesmicrofluidicspermeability

Identifiers

PMID30994358
PMCPMC7116621
OpenAlexW2952883475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.